How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be?

MLA

Ru Han, et al. “How Large Could the Public Health Impact of Introducing Recombinant Zoster Vaccination for People Aged ≥50 Years in Five Latin American Countries Be?” Human Vaccines & Immunotherapeutics, vol. 19, no. 1, Jan. 2023. EBSCOhost, https://doi.org/10.1080/21645515.2022.2164144.

APA

Ru Han, Jorge A. Gomez, Bruna de Veras, Thatiana Pinto, Adriana Guzman-Holst, Javier Nieto, & Désirée A. M. van Oorschot. (2023). How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be? Human Vaccines & Immunotherapeutics, 19(1). https://doi.org/10.1080/21645515.2022.2164144

Chicago

Ru Han, Jorge A. Gomez, Bruna de Veras, Thatiana Pinto, Adriana Guzman-Holst, Javier Nieto, and Désirée A. M. van Oorschot. 2023. “How Large Could the Public Health Impact of Introducing Recombinant Zoster Vaccination for People Aged ≥50 Years in Five Latin American Countries Be?” Human Vaccines & Immunotherapeutics 19 (1). doi:10.1080/21645515.2022.2164144.